Keith Croes
Contributing Writer
- All
- Deals
- Devices and Diagnostics
- Digital
- Genetics
- Pharma
A Closer Look at Glaukos’ Bid for Avedro
Early market reaction to Glaukos Corp.'s all-stock acquisition of Avedro Inc. was mixed; a decrease in stock price for Glaukos and an increase for Avedro. ...
Read More 
OIS@ASRS at the Ritz-Carlton Chicago: An In-depth Look at the Retina Space
CHICAGO – The extensive, intensive public and private investment in the retinal space will fill the day next Thursday, July 25, at the OIS@ASRS meeting, ...
Read More 
A Closer Look at AbbVie-Allergan Deal and Where Eye Care Fits In
NEW YORK – In what’s been called “a transformative move for both companies,” AbbVie has agreed to buy Allergan in a deal valued at $63 ...
Read More 
Why Equity and M&A Markets in Ophthalmology Are Poised for a Great Run
SAN DIEGO – Although the 10-year bull market is bound to end one of these days, the trend in ophthalmology and healthcare in general is ...
Read More